Literature DB >> 17235688

High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet's disease.

Kosei Arimura1, Naomichi Arima, Kakushi Matsushita, Masaki Akimoto, Chi Young Park, Kimiharu Uozumi, Chuwa Tei.   

Abstract

Behçet's disease (BD) is a systemic inflammatory disorder of unknown etiology, and rarely complicated with myelodysplastic syndrome (MDS). In the present study, we investigated the morphological myelodysplasia and apoptotic rate of bone marrow cells in 15 patients with BD in comparison with MDS patients. Morphological myelodysplasia of bone marrow cells was detected in 53.3% of BD, but none showed chromosomal abnormalities. The apoptotic rate in BD patients (26.1 +/- 8.4%) was significantly higher in normal controls (11.3 +/- 2.4%; p < 0.005) and significantly lower in patients with MDS (50.8 +/- 14.0%; p < 0.0001). These findings suggest that myelodysplasia in patients with BD is more frequent than expected, and possibly due to excess induction of apoptosis of bone marrow cells in BD. However, the rate of apoptotic bone marrow cells is lower than MDS, which may explain the slight peripheral cytopenia in BD, distinct from that in MDS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17235688     DOI: 10.1007/s10875-006-9064-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  17 in total

Review 1.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 2.  Behcet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature.

Authors:  K Yano; K Eguchi; K Migita; H Takashima; M Tamura; K Izumino; I Sasagawa; N Sadamori; S Nagataki
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

Review 3.  Behçet's disease associated with myelodysplastic syndromes. A case report and a review of the literature.

Authors:  E Ohno; E Ohtsuka; K Watanabe; T Kohno; K Takeoka; Y Saburi; H Kikuchi; M Nasu
Journal:  Cancer       Date:  1997-01-15       Impact factor: 6.860

4.  Atypical Behçet's syndrome in a patient with myelodysplastic syndrome.

Authors:  S Karuvannur; E Lipstein; D Brennessel; F Rosner
Journal:  Mt Sinai J Med       Date:  2001-11

5.  Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.

Authors:  Y Niwa; S Miyake; T Sakane; M Shingu; M Yokoyama
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

6.  Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.

Authors:  Elaine M Sloand; Lori Mainwaring; Monika Fuhrer; Shakti Ramkissoon; Antonio M Risitano; Keyvan Keyvanafar; Jun Lu; Atanu Basu; A John Barrett; Neal S Young
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

7.  Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.

Authors:  B Turan; H Gallati; H Erdi; A Gürler; B A Michel; P M Villiger
Journal:  J Rheumatol       Date:  1997-01       Impact factor: 4.666

8.  Apoptosis is a Common Histopathological Finding in Myelodysplasia: the Correlate of Ineffective Haematopoiesis.

Authors:  D M Clark; I A Lampert
Journal:  Leuk Lymphoma       Date:  1990

9.  Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.

Authors:  Kosei Arimura; Naomichi Arima; Kakushi Matsushita; Hideo Ohtsubo; Hiroshi Fujiwara; Toshimasa Kukita; Atsuo Ozaki; Takafumi Hagiwara; Heiichiro Hamada; Kohichiro Yoshino; Chuwa Tei
Journal:  Eur J Haematol       Date:  2004-07       Impact factor: 2.997

10.  Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.

Authors:  S Koarada; Y Haruta; Y Tada; O Ushiyama; F Morito; A Ohta; K Nagasawa
Journal:  Rheumatology (Oxford)       Date:  2004-05-18       Impact factor: 7.580

View more
  2 in total

1.  Pediatric intestinal Behçet disease complicated by myeloid malignancies.

Authors:  Kiichiro Kanamitsu; Akira Shimada; Ritsuo Nishiuchi; Tomonari Shigemura; Yozo Nakazawa; Kenichi Koike; Yuichi Kodama; Yuichi Shinkoda; Yoshifumi Kawano; Kozo Yasui; Koji Sasaki; Ryosuke Kajiwara; Hirokazu Tsukahara; Atsushi Manabe
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

2.  Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.

Authors:  Tamer A Gheita; Iman H Bassyouni; Rasha H Bassyouni
Journal:  J Clin Immunol       Date:  2012-07-26       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.